Tata Medical and Diagnostics Ltd (Tata MD) is a healthcare venture from the Tata group. Tata MD is a 100% subsidiary of Tata Sons. We are focused on developing diagnostics and medical solutions that help make health and wellness care more accessible.

Our Vision

We aspire to be a leader in the global diagnostics solutions space with breakthrough innovations across diverse conditions and Infectious diseases. We want to make care more timely through accessible, accurate, reliable and easy-to-use diagnostic tools in molecular and other diagnostics segments.

Bringing Care Closer To Patient

We aim to make care more accessible by focusing on three core principles-

Patient Centricity

Technology Innovation

Integrated Care

Reliable healthcare solutions for all

We aim to develop patient-centric solutions that are innovative and accessible to all. We do this by focussing on four key initiatives.

Healthcare Evolution

Healthcare is continuously evolving – traditional solutions simple fall short. By using a combination of innovative products, processes and technologies derived from CRISPR, we aim to better equip ourselves to overcome new challenges.

Patient-centric Solutions

Patient centricity lies at the heart of a reliable and accessible healthcare solution. With this driving insight, our healthcare delivery models have primarily been built with patient care and comfort at their very core.

Technological Capabilities

We are backed by a robust digital ecosystem. Our digital acumen combined with the power of technologies like artificial intelligence, machine learning, and internet-of-things can empower and upskill individuals and organisations to navigate the challenges in healthcare.

Connected Care

Connected care not only improves access and convenience, it also reduces costs for patients and providers. We are striving towards building a truly connected healthcare system by leveraging people, infrastructure and technology.

Board of Directors




President – Infrastructure, Defence, Aerospace and Global Corporate Affairs Tata Sons Private Limited

In the Tata Group, Banmali is the Chairman of companies like Tata Projects, Tata Housing Development Company, Tata Realty and Infrastructure Ltd. Air Asia (India) Ltd. and is on the Board of Tata Power and Tata Advanced Systems Limited.

Banmali Agrawala joined Tata Sons Private Limited as the President, Infrastructure, Defence and Aerospace in October 2017, in his second tenure with the Indian conglomerate. In his earlier role, at GE, he was President and CEO - South Asia, where he was responsible for the American multinational corporation’s operations in the South Asia region. Prior to GE, he was Executive Director (Business Development and Strategy) and a member of the Board of Tata Power. A veteran in the Energy domain, Banmali has over 30 years of global experience.

He started his career with the Wartsila Group, a Finnish manufacturing and services company, where he spent over 20 years, both in India and in Finland. At the time of leaving the Wartsila Group, he was the Managing Director of Wartsila India Ltd, the Global head of the Bio Power Industries and a member of the Global Power Plant Management Board.

An active member of the Confederation of Indian Industries (CII), Banmali has held several official positions within CII such as Chairman of the Western Regional Council, and currently is also a Member of CII’s National Council. He is a member of the Board of Directors of the US - India Business Council (USIBC) and Pratham Education Foundation. Banmali is a Mechanical Engineering graduate from Mangalore University and an alumnus of the Advanced Management Programme of Harvard Business School



Managing Director & Chief Executive Officer (MD & CEO)

Mr. Girish Krishnamurthy is a board member and Chief Executive Officer and Managing Director of Tata Medical and Diagnostics Private Limited (Tata MD), a healthcare venture from the house of Tata that aims to make healthcare affordable and accessible to all.

Using digital disruption and uncovering untapped resources, Girish has developed delivery models and process techniques that has transformed primary and tertiary healthcare – which today, touches lakhs of citizens across rural and urban India.

Girish's key focus is towards strengthening the nations response to COVID-19 through innovative testing solutions, automation for large-scale testing, and implementing COVID Safety Services that promote personal safety and promote business continuity. He is a board member for Tata Indian Institute of Skills (TIIS), a premiere institute that looks to propel India to the forefront of skill development and innovation through high-quality technical and vocational learning across sectors.

Girish holds an MBA from the University of Texas, Dallas and is a graduate in Electrical Engineering and Mathematics from the University of Madras. Armed with 30+ years of experience, he has authored and co-authored several publications in leading peer reviewed journals and has a proven history for spearheading and launching successful digital initiatives.



Non-Executive Director

Mr. KRS Jamwal is on the Board of Tata companies such as Tata UniStore, which owns Tata CLiQ, a one-of-a-kind, leading multi-brand, e-retail platform; Tata SmartFoodz, a foodtech company offering delicious ready foods using proprietary technology (where he serves as Director and Chairman of the Board); Inzpera Healthsciences, a health sciences company that markets palatable and efficacious therapeutic products (where he serves as Director and Chairman of the Board); and Tata Medical and Diagnostics, a leading-edge healthcare solutions provider (where he serves as Additional Director).

He is also a member on the board of the overseas subsidiary of Tata Industries — Qubit Investments Pte (Singapore). He represents Qubit on the boards of: Flisom AG, which manufactures flexible, lightweight solar modules at market-comparable efficiency and costs; i3 Equity Partners, a Tel Aviv based technology incubator in IoT (Internet of Things) and industrial IoT; and SDX Partners LLC, USA, which provides seed funding to student-initiated business ideas at the Massachusetts Institute of Technology, Boston.

Prior to joining Tata Industries, he served as Vice President, strategy, Group Corporate Centre, Tata Sons, supporting the then Group Chairman, Ratan Tata on special assignments such as the Investment Commission (2005-2009) and the US-India and UK-India CEO Forums.

Jamwal started his career with TAS (formerly known as Tata Administrative Services) in 1989. His initial assignments, such as with the Indian Hotels Company Ltd. (Taj Group of hotels), included project management for setting up new hotels and flight catering units, with subsequent responsibilities relating to strategic planning and mergers and acquisitions.

He holds a Post Graduate Diploma in Management from the Indian Institute of Management (IIM), Ahmedabad, where he was awarded the scholastic gold medal and the KV Srinivas Award for the best all-rounder. He holds a Bachelor’s degree in technology in petroleum engineering from the Indian School of Mines, Dhanbad, and was awarded the scholastic gold medal and the best student shield.



Non-Executive Director

Roopa Purushothaman is the chief economist and head of policy advocacy at the Tata Group.

In her role, Purushothaman drives macroeconomic research as well as all policy and advocacy initiatives as relevant to the businesses of the Tata group

Roopa is a member of the Prime Minister’s advisory committee for JNNURM (Jawaharlal Nehru National Urban Renewal Mission), and is a member of the Aspen Institute’s India Leadership Initiative.

Purushothaman has written extensively on demographics, education, income, and consumption patterns. She is the co-author of the book Bridgital Nation: Solving Technology’s People Problem, is a co-author of the path-breaking 2003 Goldman Sachs report, Dreaming with BRICS: The Path to 2050. Roopa has contributed to several publications on globalization and development along with other published papers on topics such as long-term growth in India, migration, women’s employment and global aging and consumption patterns.

Roopa holds a BA in Ethics, Politics and Economics and International Studies from Yale University and an MSc in Development Studies from the London School of Economics.



Non-Executive Director

Ms. Terri is passionate about healthcare and global health issues and has devoted more than 30 years to the field. She started her career as a clinical chemist, joined GE as an “Edison Engineer” and progressed through engineering and product management roles in Magnetic Resonance Imaging, Computed Tomography and Positron Emission Tomography. She also led GE’s US Women’s Health business, and global businesses including GE Ultrasound and GE Molecular Imaging.

Prior to her CIO role at GE Healthcare, Ms. Terri served as President and CEO of GE Healthcare India, leading GE’s vision of “healthymagination” in India – an approach that aims to provide better healthcare for more people through solutions that bring costs down, increase access and improve the quality of healthcare.

Ms. Terri earned her master's degree in Biomedical Engineering from the University of Texas, and her bachelor’s in Medical Technology from the University of Tennessee. She is a board member of several healthcare organizations and is active in community-based health projects.